WO2024046715 - SILANES AND CURABLE COMPOSITIONS CONTAINING THEM
National phase entry is expected:
Publication Number
WO/2024/046715
Publication Date
07.03.2024
International Application No.
PCT/EP2023/071894
International Filing Date
08.08.2023
Title **
[English]
SILANES AND CURABLE COMPOSITIONS CONTAINING THEM
[French]
SILANES ET COMPOSITIONS DURCISSABLES LES CONTENANT
Applicants **
HENKEL AG & CO. KGAA
Inventors
GEITNER, Felix
GUTACKER, Andrea
DURACU, Adrian
ZHAO, Ligang
BRANDT, Adrian
BECK, Horst
DELLACQUA, Andrea
TIN, Sergey
DE VRIES, Johannes Gerardus
Priority Data
22193121.5
31.08.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
* |
| Recordal of a Change of the Applicant's Name/Address | * |
| Type of Assignment | * |
| Applicant's Legal Status | * |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under | * |
| Patent Delivery | * |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2052 | |
| EPO | Filing, Examination, Granting | 8387 | |
| Japan | Filing, Examination, Granting | 2247 | |
| South Korea | Filing, Examination, Granting | 2251 | |
| USA | Filing, Examination, Granting | 5940 |
Total:
20,877
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
stands for: a substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclyl or heteroaryl group; and m independently stands for 0 or 1, preferably 1. The invention also relates to curable compositions containing said silane and a curable polyorganosiloxane endcapped with such silanes. The silane acts as a crosslinker in the curable compositions and is notable particularly for being obtainable from renewable resources, providing for a high overall performance..[French]
représentant : un groupe alkyle, alcényle, alcynyle, cycloalkyle, aryle, hétérocyclyle ou hétéroaryle substitué ou non substitué ; et m représente indépendamment 0 ou 1, de préférence 1. L'invention concerne également des compositions durcissables contenant ledit silane et un polyorganosiloxane durcissable coiffé par de tels silanes. Le silane agit comme un agent de réticulation dans les compositions durcissables et est remarquable en particulier pour pouvoir être obtenu à partir de ressources renouvelables, ce qui permet d'obtenir une performance globale élevée.